The application has been submitted under the European Medicines Agency’s (EMEA’s) centralized procedure for product approval, which provides review and approval for all countries within the EU. The
The drug reduces glucose levels in the blood, and also increases levels of high-density lipoprotein, or ‘good’ cholesterol. Pargluva is an investigational oral medication that, if approved, would
In the study, the safety and efficacy of Remoxy was compared to placebo in osteoarthritic patients with moderate-to-severe chronic pain. This phase III study enrolled 209 patients in
Tramadol ER has been approved for the treatment of moderate to moderately severe chronic pain in once-daily 100mg, 200mg and 300mg dosage strengths. Biovail is the first and
PRO 140 is a humanized monoclonal antibody against CCR5 that is designed to protect healthy immune system cells from infection by HIV, the causative agent of AIDS. Binding
Exubera is a form of insulin that is inhaled through the mouth into the lungs prior to eating, using a proprietary inhalation device and powdered insulin formulation developed
The collaboration will include the continued development of a new formulation of Intal utilizing hydrofluoroalkane (HFA), an environmentally friendly propellant. King and Inyx will co-market Intal and Tilade
This bystander effect occurs when the therapeutic protein binds to certain receptors on nearby cancer cells. This activity in breast cancer cells is another mechanism by which INGN
Under the terms of the agreement, MedImmune will be responsible for the clinical development and commercialization of any resulting products. VasGene will provide research and development support and
The investigation has been useful in establishing a maximum tolerated dose for GCS-100 and providing safety and pharmacokinetic data that supports the company’s blood-borne cancer programs. Furthermore, of
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.